MOG-IgG in primary and secondary chronic progressive multiple sclerosis: a multicenter study of 200 patients and review of the literature
Antibodies to human full-length myelin oligodendrocyte glycoprotein (MOG-IgG) as detected by new-generation cell-based assays have recently been described in patients presenting with acute demyelinating disease of the central nervous system, including patients previously diagnosed with multiple scle...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
19 March 2018
|
| In: |
Journal of neuroinflammation
Year: 2018, Jahrgang: 15 |
| ISSN: | 1742-2094 |
| DOI: | 10.1186/s12974-018-1108-6 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/s12974-018-1108-6 Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s12974-018-1108-6 
|
| Verfasserangaben: | S. Jarius, K. Ruprecht, J.P. Stellmann, A. Huss, I. Ayzenberg, A. Willing, C. Trebst, M. Pawlitzki, A. Abdelhak, T. Grüter, F. Leypoldt, J. Haas, I. Kleiter, H. Tumani, K. Fechner, M. Reindl, F. Paul and B. Wildemann |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1571807616 | ||
| 003 | DE-627 | ||
| 005 | 20230426124234.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180409s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s12974-018-1108-6 |2 doi | |
| 035 | |a (DE-627)1571807616 | ||
| 035 | |a (DE-576)501807616 | ||
| 035 | |a (DE-599)BSZ501807616 | ||
| 035 | |a (OCoLC)1263971821 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Jarius, Sven |e VerfasserIn |0 (DE-588)1054615918 |0 (DE-627)791654818 |0 (DE-576)410367478 |4 aut | |
| 245 | 1 | 0 | |a MOG-IgG in primary and secondary chronic progressive multiple sclerosis |b a multicenter study of 200 patients and review of the literature |c S. Jarius, K. Ruprecht, J.P. Stellmann, A. Huss, I. Ayzenberg, A. Willing, C. Trebst, M. Pawlitzki, A. Abdelhak, T. Grüter, F. Leypoldt, J. Haas, I. Kleiter, H. Tumani, K. Fechner, M. Reindl, F. Paul and B. Wildemann |
| 264 | 1 | |c 19 March 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.04.2018 | ||
| 520 | |a Antibodies to human full-length myelin oligodendrocyte glycoprotein (MOG-IgG) as detected by new-generation cell-based assays have recently been described in patients presenting with acute demyelinating disease of the central nervous system, including patients previously diagnosed with multiple sclerosis (MS). However, only limited data are available on the relevance of MOG-IgG testing in patients with chronic progressive demyelinating disease. It is unclear if patients with primary progressive MS (PPMS) or secondary progressive MS (SPMS) should routinely be tested for MOG-IgG. | ||
| 650 | 4 | |a Antibodies | |
| 650 | 4 | |a Immunoglobulin G | |
| 650 | 4 | |a MOG-IgG | |
| 650 | 4 | |a Myelin oligodendrocyte glycoprotein (MOG) | |
| 650 | 4 | |a Neuromyelitis optica spectrum disorders (NMOSD) | |
| 650 | 4 | |a Primary chronic progressive MS (PPMS) | |
| 650 | 4 | |a Secondary chronic progressive MS (SPMS) | |
| 700 | 1 | |a Haas, Jürgen |e VerfasserIn |0 (DE-588)1073216810 |0 (DE-627)828662290 |0 (DE-576)434731749 |4 aut | |
| 700 | 1 | |a Wildemann, Brigitte |e VerfasserIn |0 (DE-588)110203844 |0 (DE-627)510150004 |0 (DE-576)171831330 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of neuroinflammation |d London : BioMed Central, 2004 |g 15(2018) Artikel-Nummer 88, 5 Seiten |h Online-Ressource |w (DE-627)391784781 |w (DE-600)2156455-3 |w (DE-576)12192985X |x 1742-2094 |7 nnas |a MOG-IgG in primary and secondary chronic progressive multiple sclerosis a multicenter study of 200 patients and review of the literature |
| 773 | 1 | 8 | |g volume:15 |g year:2018 |a MOG-IgG in primary and secondary chronic progressive multiple sclerosis a multicenter study of 200 patients and review of the literature |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12974-018-1108-6 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1186/s12974-018-1108-6 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180409 | ||
| 993 | |a Article | ||
| 994 | |a 2018 | ||
| 998 | |g 110203844 |a Wildemann, Brigitte |m 110203844:Wildemann, Brigitte |d 910000 |d 911100 |e 910000PW110203844 |e 911100PW110203844 |k 0/910000/ |k 1/910000/911100/ |p 18 |y j | ||
| 998 | |g 1073216810 |a Haas, Jürgen |m 1073216810:Haas, Jürgen |d 910000 |d 911100 |e 910000PH1073216810 |e 911100PH1073216810 |k 0/910000/ |k 1/910000/911100/ |p 12 | ||
| 998 | |g 1054615918 |a Jarius, Sven |m 1054615918:Jarius, Sven |d 910000 |d 911100 |e 910000PJ1054615918 |e 911100PJ1054615918 |k 0/910000/ |k 1/910000/911100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1571807616 |e 3005338126 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"part":{"year":"2018","volume":"15","text":"15(2018) Artikel-Nummer 88, 5 Seiten"},"recId":"391784781","disp":"MOG-IgG in primary and secondary chronic progressive multiple sclerosis a multicenter study of 200 patients and review of the literatureJournal of neuroinflammation","id":{"zdb":["2156455-3"],"issn":["1742-2094"],"eki":["391784781"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2004 -"],"origin":[{"publisherPlace":"London","dateIssuedKey":"2004","dateIssuedDisp":"2004-","publisher":"BioMed Central"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Journal of neuroinflammation","title":"Journal of neuroinflammation","subtitle":"JNI"}],"note":["Gesehen am 12.07.10"],"titleAlt":[{"title":"JNI"}]}],"person":[{"roleDisplay":"VerfasserIn","role":"aut","family":"Jarius","given":"Sven","display":"Jarius, Sven"},{"display":"Haas, Jürgen","given":"Jürgen","family":"Haas","role":"aut","roleDisplay":"VerfasserIn"},{"display":"Wildemann, Brigitte","given":"Brigitte","family":"Wildemann","role":"aut","roleDisplay":"VerfasserIn"}],"name":{"displayForm":["S. Jarius, K. Ruprecht, J.P. Stellmann, A. Huss, I. Ayzenberg, A. Willing, C. Trebst, M. Pawlitzki, A. Abdelhak, T. Grüter, F. Leypoldt, J. Haas, I. Kleiter, H. Tumani, K. Fechner, M. Reindl, F. Paul and B. Wildemann"]},"id":{"eki":["1571807616"],"doi":["10.1186/s12974-018-1108-6"]},"recId":"1571807616","note":["Gesehen am 09.04.2018"],"title":[{"subtitle":"a multicenter study of 200 patients and review of the literature","title":"MOG-IgG in primary and secondary chronic progressive multiple sclerosis","title_sort":"MOG-IgG in primary and secondary chronic progressive multiple sclerosis"}],"language":["eng"],"origin":[{"dateIssuedKey":"2018","dateIssuedDisp":"19 March 2018"}]} | ||
| SRT | |a JARIUSSVENMOGIGGINPR1920 | ||